| Titre : | Drug overdose epidemic colliding with COVID-19: What the United States can learn from France (2022) |
| Auteurs : | M. J. NGUEMENI TIAKO ; J. NETHERLAND ; H. HANSEN ; M. JAUFFRET-ROUSTIDE |
| Type de document : | Article : Périodique |
| Dans : | American Journal of Public Health (Vol.112, n°S2, April 2022) |
| Article en page(s) : | S128-S132 |
| Langues: | Anglais |
| Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
| Mots-clés : |
Thésaurus géographique FRANCE ; ETATS-UNISThésaurus mots-clés EPIDEMIE ; SURDOSE ; PRISE EN CHARGE ; NALOXONE ; TRAITEMENT DE MAINTENANCE ; TRAITEMENT INTEGRE ; MODELE ; MORTALITE ; REDUCTION DES RISQUES ET DES DOMMAGES ; ACCES AUX SOINS |
| Résumé : | The United States has long faced a lethal drug overdose epidemic, which is now colliding with the COVID-19 pandemic. Overdose rates significantly rose in 2020 compared with 2019, and people with opioid use disorder (OUD) have contracted COVID-19 and experienced significantly greater severity and mortality compared with the general population. These deaths are preventable and reflect misplaced policy priorities. [Extract] |
| Domaine : | Drogues illicites / Illicit drugs |
| Refs biblio. : | 33 |
| Affiliation : |
Brigham and Women's Hospital, Boston, MA, USA Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY, USA Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles, USA Institut National de la Santé et de la Recherche Médicale in Paris, France |
| Lien : | https://doi.org/10.2105/ajph.2022.306763 |
Accueil
